Short Interest in Silo Pharma, Inc. (NASDAQ:SILO) Rises By 38.7%

Silo Pharma, Inc. (NASDAQ:SILO) saw a significant increase in short interest during the month of March. As of March 15th, there was short interest totalling 181,200 shares, an increase of 38.7% from the February 28th total of 130,600 shares. Currently, 4.2% of the shares of the company are short sold. Based on an average daily trading volume, of 2,900,000 shares, the days-to-cover ratio is currently 0.1 days.

Silo Pharma Trading Down 3.4 %

Shares of SILO opened at $1.13 on Wednesday. The company’s 50 day simple moving average is $1.47 and its 200-day simple moving average is $1.24. The firm has a market cap of $5.07 million, a PE ratio of -0.93 and a beta of 0.01. Silo Pharma has a 12-month low of $0.77 and a 12-month high of $4.50.

Silo Pharma (NASDAQ:SILO) last announced its earnings results on Friday, March 28th. The company reported ($0.41) EPS for the quarter. The business had revenue of $0.02 million during the quarter. Silo Pharma had a negative net margin of 5,255.05% and a negative return on equity of 61.38%.

About Silo Pharma

Silo Pharma Inc operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations and drug delivery systems.